We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Feather Safety Razor

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

Mini-Sponge Wound Dressing Controls Hemorrhage

By HospiMedica International staff writers
Posted on 20 Dec 2015
Print article
Image: The XStat 30 device (Photo courtesy of RevMedX).
Image: The XStat 30 device (Photo courtesy of RevMedX).
A syringe-like device injects a large number of tiny, rapidly expanding sponges into a wound cavity, quickly controlling bleeding when tourniquets are not an option.

The XStat 30 device is a 30 mm diameter applicator shaped like a large syringe that holds 92 tablet-sized, mini-cellulose sponges that are coated with an absorbent hemostatic agent. Once injected into a bleeding wound, the compressed sponges expand when they come in contact with fluids, thus rapidly filling a volume substantially larger than that of their compressed state. Besides helping to provide hemostasis for up to four hours until surgery, the sponges also provide a surface on which blood clots can begin to form.

The Xstat 30 is intended for use in patients at high risk for immediate, life-threatening and severe hemorrhagic shock and for use in non-compressible junctional wounds, such as the armpit or groin, or when definitive care at an emergency care facility cannot be reached within minutes. It is not indicated for use in the thorax, pleural cavity, mediastinum, abdomen, retroperitoneal space, sacral space, or in tissues above the clavicle. Since the sponges are eventually removed, each has a tiny radiopaque marker that is visible on X-ray.

The XStat 30 device, a product of RevMedx (Wilsonville, OR, USA), will be marketed in packages of one or three applicators, each with a telescoping handle and a sealed valve tip; the telescoping mechanism allows the handle to be stored in a shortened state to maximize compactness. The number of sponges necessary to stop bleeding depends on the size and depth of the wound, with each applicator capable of absorbing about 570 mL blood, and with up to three applicators indicated for use on a given patient.

“The majority of people with massive abdominal bleeding die before they reach the hospital,” said David King, MD, a trauma surgeon at Massachusetts General Hospital (Boston, MA, USA). “Many of these deaths could be prevented if we were able to temporarily stabilize a patient long enough to reach a trauma center.”

Related Links:

RevMedx



Print article

Channels

Surgical Techniques

view channel
Image: A minimally invasive diagnostic biomarker strategy has proven successful in detecting early esophageal cancer (Photo courtesy of Pexels)

Minimally Invasive Device Combined With Molecular Biomarkers Detects Early Esophageal Cancer

Esophageal cancer remains the sixth-most common cause of cancer death worldwide, claiming the lives of more than half a million people annually. Esophageal squamous cell carcinoma (ESCC) comprises 80%... Read more

Patient Care

view channel
Image: Future wearable health tech could measure gases released from skin (Photo courtesy of Pexels)

Wearable Health Tech Could Measure Gases Released From Skin to Monitor Metabolic Diseases

Most research on measuring human biomarkers, which are measures of a body’s health, rely on electrical signals to sense the chemicals excreted in sweat. But sensors that rely on perspiration often require... Read more

Health IT

view channel
Image: AI can reveal a patient`s heart health (Photo courtesy of Mayo Clinic)

AI Trained for Specific Vocal Biomarkers Could Accurately Predict Coronary Artery Disease

Earlier studies have examined the use of voice analysis for identifying voice markers associated with coronary artery disease (CAD) and heart failure. Other research groups have explored the use of similar... Read more
Copyright © 2000-2022 Globetech Media. All rights reserved.